Overtime

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of mild pain associated with muscular strain, arthritis, and simple back pain. It is important to note that this medication does not cure any underlying disease.

There are no teratogenic effects associated with this drug, and no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should instruct patients to use the product only as directed. Prior to the first application, it is recommended to rub a small amount on the skin to check for sensitivity. The product should be shaken well before each use to ensure proper consistency.

For application, patients should gently rub the product over the painful areas. It is important to allow the area to dry completely before coming into contact with clothing or bedding to prevent staining. After application, patients should wash their hands thoroughly to avoid unintentional transfer of the product.

Patients should not exceed four applications per day. Additionally, the product is contraindicated for use in individuals who are pregnant or nursing. In the event of accidental contact with the eyes, patients should rinse the eyes with cold water immediately and seek medical attention.

Contraindications

Use of this product is contraindicated in the following situations:

• Application on cuts or infected skin is prohibited due to the risk of exacerbating the condition.

• The product should not be used in children under 12 years of age, as safety and efficacy have not been established in this population.

• Avoid large amounts of the product, particularly on raw or blistered skin, to prevent potential adverse effects.

• Use is contraindicated in individuals with known allergies to any ingredients in the formulation, including PABA, aspirin products, or sulfa, due to the risk of allergic reactions.

Warnings and Precautions

For external use only, this product must not be applied to the eyes, mouth, mucous membranes, or genital areas. It is imperative to prevent treated skin from coming into contact with infants or pets. The application should not involve tight bandaging, nor should it be used in conjunction with heating pads or other topical pain products. Additionally, users should be aware that the product may cause staining on furniture, clothing, or bedding.

General precautions should be observed when using this product. It is contraindicated for application on cuts or infected skin, in children under 12 years of age, or in large amounts, particularly over raw or blistered skin. Individuals with known allergies to any ingredients, including PABA, aspirin products, or sulfa, should avoid use. The product should be stored at temperatures below 90°F (32°C) to maintain its efficacy.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Patients are instructed to discontinue use and consult a healthcare provider if they experience severe undiagnosed pain, if pain worsens or persists beyond 7 days, if pain resolves and then recurs within a few days, or if any itching or rash develops.

Side Effects

Patients using this product may experience a range of adverse reactions. Serious adverse reactions include severe undiagnosed pain, which necessitates immediate cessation of use and consultation with a physician. Additionally, patients should discontinue use if pain worsens or persists for more than 7 days, or if pain resolves and then recurs within a few days.

Common adverse reactions may include localized itching or rash, which also warrant stopping the use of the product and seeking medical advice.

It is important to note that this product is for external use only and should not be applied to the eyes, mouth, mucous membranes, or genital areas. Patients are advised against tightly bandaging the treated area, using heating pads in conjunction with the product, or applying it alongside other topical pain products. Furthermore, care should be taken to prevent treated skin from coming into contact with infants or pets, as the product may cause harm. Users should also be aware that the product may stain furniture, clothing, or bedding.

Drug Interactions

There are currently no documented drug interactions or interactions with laboratory tests associated with this medication. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time. Healthcare professionals should continue to assess individual patient circumstances and consider any potential interactions based on the patient's overall medication regimen.

Packaging & NDC

Below are the non-prescription pack sizes of Overtime (methyl salicylate, menthol and capsaicin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not be administered this medication. Safety and efficacy have not been established in this age group, and caution is advised when considering treatment options for younger children.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are nursing should not use this medication. The potential risks associated with the use of this drug during pregnancy have not been established, and there is insufficient data to determine its safety profile in this population. Healthcare professionals are advised to consider alternative treatments for women who are pregnant or breastfeeding to avoid any potential adverse effects on fetal outcomes or nursing infants.

Lactation

Lactating mothers are advised not to use this medication more than four times daily. The safety of this medication during lactation has not been established, and it is not recommended for use in nursing mothers. There is no available data on the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution should be exercised when considering its use in lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted in these patients to ensure safety and therapeutic effectiveness.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential risks associated with excessive administration of the medication.

Healthcare providers should be aware that symptoms of overdosage may vary depending on the pharmacological properties of the drug and the individual patient's response. In cases where overdosage is suspected, immediate medical evaluation is recommended.

Management of overdosage should include supportive care and symptomatic treatment. Healthcare professionals are advised to monitor the patient closely for any adverse effects and to implement appropriate interventions based on the clinical presentation.

In the event of an overdose, contacting a poison control center or seeking guidance from a medical toxicologist may be beneficial for tailored management strategies. It is crucial to document the incident thoroughly and report any adverse events to the relevant regulatory authorities as per local guidelines.

Overall, while specific overdosage information is not provided, the importance of prompt recognition and management cannot be overstated in ensuring patient safety.

Nonclinical Toxicology

There is currently no available information regarding teratogenic or non-teratogenic effects associated with the compound. Additionally, no data has been provided concerning nonclinical toxicology, including animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. Healthcare providers should emphasize the importance of avoiding the application of the product on cuts or infected skin, particularly in children under 12 years of age, and caution against using it in large amounts, especially over raw or blistered skin.

Patients with known allergies to any ingredients, including PABA, aspirin products, or sulfa, should be informed to refrain from using the product. It is also essential to instruct patients to store the product below 90°F (32°C) to maintain its efficacy.

Healthcare providers should discuss the appropriate use of the product for severe undiagnosed pain and advise patients to seek medical attention if their pain worsens or persists for more than 7 days. Additionally, patients should be informed to report any recurrence of pain after it has cleared up, as well as any occurrence of itching or rash, as these may indicate a need for reevaluation of their treatment.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a controlled environment, maintaining a temperature below 90°F (32°C) to ensure its stability and efficacy. Proper storage conditions are critical to preserving the integrity of the product throughout its shelf life.

Additional Clinical Information

The product is administered topically and should be used only as directed. Patients are advised not to exceed four applications per day and to avoid use during pregnancy or while nursing. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Overtime, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)